Phenylbutazone Toxicosis in Equidae: A Biochemical and Pathophysiologic Study

David Snow, Tonia Douglas, H. Thompson, J.J. Parkins, P.H. Holmes

American Journal of Veterinary Research · 1981 · 50 citations · 0 references

Concepts

Abstract

SUMMARY Toxic effects of phenylbutazone ( pbz ) in ponies and horses were studied, using a variety of biochemical, pathophysiologic, and pathologic methods. At dosage levels of 10 to 12 mg/kg of body weight/day for 8 to 10 days, ponies frequently developed clinical signs of toxicosis characterized by hypoproteinemia. Studies using 51 CrCl 3 demonstrated that pbz caused a protein-losing gastroenteropathy. The plasma loss was usually associated with gastrointestinal ulceration, but sometimes occurred without obvious lesions in mildly affected animals. Similar studies (8.2 mg/kg/day for 13 days) in Thoroughbreds indicated that they were less susceptible to pbz toxicity; however, a degree of hypoproteinemia occurred in 4 of 6 treated Thoroughbreds.